Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Vitamin A analogues do not raise fracture risk

By News team

Large doses of systemic vitamin A analogues are not associated with an increased risk of fracture, a study has shown (Archives of Dermatology 2010;146:478).

The study of 124,655 patients with fractures and 373,962 control patients found no relationship between fracture risk and increasing dose of, or increasing duration of treatment with, vitamin A analogues.

Analysing vitamin A analogues isotretinoin and acitretin separately did not alter the findings.

Citation: Clinical Pharmacist URI: 11012806

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.


Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.